Pim Gal

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Hypertensive Patients

Top Venues

Clinical and translational science

British journal of clinical pharmacology

Journal of experimental pharmacology

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Marella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, Wouter A Bakker, Hemme J Hijma, Geert Jan Groeneveld, Marieke L de Kam, Jacobus Burggraaf, Matthijs Moerland
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress. Journal of experimental pharmacology 16 (2024)
Sebastiaan J W van Kraaij, Diana R Pereira, Bastiaan Smal, Luciana Summo, Anne Konkel, Janine Lossie, Andreas Busjahn, Tom N Grammatopoulos, Erica Surya Klaassen, Robert Fischer, Wolf-Hagen Schunck, Pim Gal, Matthijs Moerland
Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial disease. Clinical and translational science (2023)
Sebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, Erica Surya Klaassen, Francis Dijkstra, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator. Clinical and translational science (2023)
Sebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, Erica Surya Klaassen, Francis Dijkstra, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
First-in-human trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator. Clinical and translational science (2023)
Gerardus J Hassing, Michiel Joost van Esdonk, Gerard J P van Westen, Adam A Cohen, Jacobus Burggraaf, Pim Gal
Dose escalations in phase I studies: Feasibility of interpreting blinded pharmacodynamic data. British journal of clinical pharmacology 88 (12) (2022)
Willem O Elzinga, Samantha Prins, Laura G J M Borghans, Pim Gal, Gabriel A Vargas, Geert Jan Groeneveld, Robert-Jan Doll
Detection of Clenbuterol-Induced Changes in Heart Rate Using At-Home Recorded Smartwatch Data: Randomized Controlled Trial. JMIR formative research 5 (12) (2021)